AbbVie Inc. urged a Virginia federal court to add more than four months to a patent for its Venclexta cancer drug, arguing the US Patent and …
AbbVie Inc. urged a Virginia federal court to add more than four months to a patent for its Venclexta cancer drug, arguing the US Patent and …